Pharmacists in Newport, Arkansas


13 Pharmacists found in Newport
male pharmacist

Aaron Bright, PHARM D


Pharmacist
1117 Mclain St Ste 400, Newport, AR 72112
870-523-5555     870-523-6337

female pharmacist

Amanda Kay Quick, PHARMD


Pharmacist
1211 Highway 367 N, Newport, AR 72112
870-523-2383    

female pharmacist

Dr. Amelia Falwell Smith


Pharmacist
1211 Highway 367 N, Newport, AR 72112
870-523-2383     870-523-2850



female pharmacist

Dr. Caitlin Marie English, PHARMD


Pharmacist
1211 Ar-367 N, Newport, AR 72112
870-523-2383     870-523-2850

female pharmacist

Carissa Young, PHARMD


Pharmacist
2401 Malcolm Ave, Newport, AR 72112
870-217-0170    

male pharmacist

Mr. Fred Lee Melder Sr., P.D.


Pharmacist
1705 Malcolm Ave, Newport, AR 72112
870-523-9228     870-523-8502

female pharmacist

Dr. Jennifer Lanelle Wynn, PHARMD


Pharmacist
1303 Mclain St, Newport, AR 72112
870-523-5888     870-523-9980

female pharmacist

Dr. Karen Chaplain, PHARM.D.


Pharmacist
2401 Malcolm Ave, Newport, AR 72112
870-217-0170    

female pharmacist

Dr. Lori Ward, PHARM D


Pharmacist
2200 Malcolm Ave, Newport, AR 72112
870-523-9472    

female pharmacist

Mary Kathryn Davis, PHARMD


Pharmacist
2200 Malcolm Ave Ste D, Newport, AR 72112
870-523-9472     870-523-9364

male pharmacist

Dr. Michael Bryant Jr.


Pharmacist
1211 Highway 367 N, Newport, AR 72112
870-523-2383    

female pharmacist

Parker Lynn White


Pharmacist
1303 Mclain St, Newport, AR 72112
870-523-5888    

male pharmacist

William Eric Shoffner


Pharmacist
1117 Mclain St Ste 400, Newport, AR 72112
870-523-5555     870-523-6337


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.